Roche will publish its Sales Results for the 3rd Quarter of 2022 prior to the opening of the Swiss Stock Exchange on Tuesday, 18 October 2022.

The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters:

Severin Schwan, CEO Roche Group

Bill Anderson, CEO Roche Pharmaceuticals

Thomas Schinecker, CEO Roche Diagnostics

Alan Hippe, Chief Financial and IT Officer

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

A replay of the webcast will be available via > ir.roche.com

Contact:

Roche Investor

Dr. Bruno Eschli

Phone: +41 61 68-75284

Email: bruno.eschli@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

Email: birgit.masjost@roche.com

Investor

North America

Loren Kalm

Phone: +1 650 225 3217

Email: kalm.loren@gene.com

Dr. Sabine Borngraber

Phone: +41 61 68-88027

Email: sabine.borngraeber@roche.com

Dr. Gerard Tobin

Phone: +41 61 68-72942

Email: gerard.tobin@roche.com

(C) 2022 Electronic News Publishing, source ENP Newswire